Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Nooka

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Expert Review of Hematology|November 14, 2012
Sequential or combination therapy for multiple myelomaAjay Nooka, Sagar Lonial
Current Hematologic Malignancy Reports|May 8, 2010
Improving induction therapy in multiple myelomaAjay Nooka, Charise Gleason, Sagar Lonial
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Supportive therapies in multiple myelomaCharise Gleason, Ajay Nooka, Sagar Lonial
Cancer Journal (Sudbury, Mass.)|December 17, 2009
The importance of complete response in outcomes in myelomaAjay Nooka, Jonathan Kaufman, Sagar Lonial
Biologics : Targets & Therapy|February 7, 2013
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomibAjay Nooka, Charise Gleason, Daniela Casbourne, et al.
Current Drug Delivery|October 26, 2011
Clinical use of rituximab in patients with HIV related lymphoma and Multicentric Castleman's diseaseErin Reid, Ajay Nooka, Jawaunna Blackmon, et al.
Lancet (London, England)|June 8, 2019
Registering a CD38 antibody upfront for multiple myelomaCraig C Hofmeister, Ajay Nooka, Jonathan L Kaufman, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2011
Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literatureAjay Nooka, Pareen J Shenoy, Rajni Sinha, et al.
The Journal of Emergency Medicine|February 20, 2007
Bilateral adrenal hemorrhage: an overlooked cause of hypotensionMichalis K Picolos, Ajay Nooka, Anu Bhalla Davis, et al.
Blood Advances|August 7, 2024
Improving reporting of infection events in clinical trialsHeinz Ludwig, Nikhil C Munshi, Evangelos Terpos, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Expert Review of Hematology|November 14, 2012
Sequential or combination therapy for multiple myelomaAjay Nooka, Sagar Lonial
Current Hematologic Malignancy Reports|May 8, 2010
Improving induction therapy in multiple myelomaAjay Nooka, Charise Gleason, Sagar Lonial
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Supportive therapies in multiple myelomaCharise Gleason, Ajay Nooka, Sagar Lonial
Cancer Journal (Sudbury, Mass.)|December 17, 2009
The importance of complete response in outcomes in myelomaAjay Nooka, Jonathan Kaufman, Sagar Lonial
Biologics : Targets & Therapy|February 7, 2013
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomibAjay Nooka, Charise Gleason, Daniela Casbourne, et al.
Current Drug Delivery|October 26, 2011
Clinical use of rituximab in patients with HIV related lymphoma and Multicentric Castleman's diseaseErin Reid, Ajay Nooka, Jawaunna Blackmon, et al.
Lancet (London, England)|June 8, 2019
Registering a CD38 antibody upfront for multiple myelomaCraig C Hofmeister, Ajay Nooka, Jonathan L Kaufman, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2011
Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literatureAjay Nooka, Pareen J Shenoy, Rajni Sinha, et al.
The Journal of Emergency Medicine|February 20, 2007
Bilateral adrenal hemorrhage: an overlooked cause of hypotensionMichalis K Picolos, Ajay Nooka, Anu Bhalla Davis, et al.
Blood Advances|August 7, 2024
Improving reporting of infection events in clinical trialsHeinz Ludwig, Nikhil C Munshi, Evangelos Terpos, et al.
Pageof 5